The ELMS program is similar to what Team Penske did with its partial season WEC LMP2 entry in 2022, ahead of its Hypercar/GTP effort following year, as well as Genesis’ ‘Trajectory Program’ with IDEC ...
motorsport.com on MSN
Ford reveals Logan Sargeant among first WEC Hypercar drivers
As part of the Ford Racing launch event in the US, the Blue Oval revealed further details about its return to the top echelon ...
Ford Racing has shared key updates about its forthcoming 2027 FIA WEC Hypercar program as part of its 2026 season launch event in Detroit, Michigan on Thursday.The main headline is that the Blue Oval ...
GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders, today announced the appointment of Petra Duda, M.D., Ph.D., as Chief Medical Officer. Dr. Duda brings ...
Autosport on MSN
Ford signs Sargeant among first WEC Hypercar drivers
As part of the Ford Racing launch event in the US, the Blue Oval revealed further details about its return to the top echelon ...
Illinois Department of Early ChildhoodKathleen Carolyn "KC" Stralka will serve as the Assistant Secretary of Project Management & Operational Excellence ...
Arch Biopartners Inc. ('Arch” or the 'Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr.
Boston Scientific Corp. (NYSE: BSX) is buying Penumbra Inc. (NYSE: PEN) in a $14.5 billion bid to acquire new technologies ...
Kestrel Therapeutics is among the latest companies to move to Watertown, opening a new headquarters location on the Arsenal ...
Adimab's latest partner program to receive approval is GSK's Exdensur (depemokimab), approved in the US for the treatment of severe asthma with an eosinophilic phenotype and in the UK and Japan for ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results